| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-actinin binding | 6.71e-05 | 31 | 51 | 3 | GO:0051393 | |
| GeneOntologyMolecularFunction | actinin binding | 1.80e-04 | 43 | 51 | 3 | GO:0042805 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 1.18e-06 | 9 | 51 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 6.10e-05 | 31 | 51 | 3 | GO:0045048 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 1.21e-06 | 9 | 52 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 5.18e-06 | 14 | 52 | 3 | GO:0072379 | |
| Domain | DUF2012 | 7.21e-08 | 4 | 50 | 3 | PF09430 | |
| Domain | DUF2012 | 7.21e-08 | 4 | 50 | 3 | IPR019008 | |
| Domain | Carb-bd-like_fold | 1.00e-06 | 8 | 50 | 3 | IPR013784 | |
| Domain | CarboxyPept_regulatory_dom | 5.07e-06 | 13 | 50 | 3 | IPR014766 | |
| Domain | - | 5.07e-06 | 13 | 50 | 3 | 2.60.40.1120 | |
| Domain | CarboxyPept-like_regulatory | 1.20e-05 | 17 | 50 | 3 | IPR008969 | |
| Domain | TNFR | 2.19e-03 | 26 | 50 | 2 | SM00208 | |
| Domain | ASX_HYDROXYL | 2.43e-03 | 100 | 50 | 3 | PS00010 | |
| Domain | hEGF | 2.54e-03 | 28 | 50 | 2 | PF12661 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.87e-03 | 106 | 50 | 3 | IPR000152 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 3.52e-03 | 33 | 50 | 2 | IPR001368 | |
| Domain | EGF | 3.58e-03 | 235 | 50 | 4 | SM00181 | |
| Domain | ZF_CCHC | 3.95e-03 | 35 | 50 | 2 | PS50158 | |
| Domain | EGF_CA | 4.26e-03 | 122 | 50 | 3 | SM00179 | |
| Domain | EGF-like_dom | 4.39e-03 | 249 | 50 | 4 | IPR000742 | |
| Domain | EGF-like_Ca-bd_dom | 4.46e-03 | 124 | 50 | 3 | IPR001881 | |
| Domain | EGF | 4.66e-03 | 126 | 50 | 3 | PF00008 | |
| Pubmed | 3.15e-09 | 3 | 52 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 3.15e-09 | 3 | 52 | 3 | 25576386 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 1.26e-08 | 4 | 52 | 3 | 31833031 | |
| Pubmed | 1.26e-08 | 4 | 52 | 3 | 9267806 | ||
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.76e-07 | 8 | 52 | 3 | 15257293 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 2.63e-07 | 9 | 52 | 3 | 36261522 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 5.16e-07 | 11 | 52 | 3 | 32820719 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 28339092 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 30540937 | ||
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 1.38e-05 | 31 | 52 | 3 | 19136429 | |
| Pubmed | 1.67e-05 | 33 | 52 | 3 | 30783098 | ||
| Pubmed | Planar cell polarity pathway regulates nephrin endocytosis in developing podocytes. | 2.19e-05 | 5 | 52 | 2 | 23824190 | |
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 4.02e-05 | 424 | 52 | 6 | 21731673 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | 4.94e-05 | 1451 | 52 | 10 | 30550785 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 33568778 | ||
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 8.92e-05 | 156 | 52 | 4 | 30409884 | |
| Pubmed | 9.79e-05 | 10 | 52 | 2 | 35216141 | ||
| Pubmed | Origin, fate and dynamics of macrophages at central nervous system interfaces. | 9.79e-05 | 10 | 52 | 2 | 27135602 | |
| Pubmed | 1.17e-04 | 63 | 52 | 3 | 31266804 | ||
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 21746835 | ||
| Pubmed | 1.52e-04 | 339 | 52 | 5 | 30415952 | ||
| Pubmed | Single-cell gene profiling defines differential progenitor subclasses in mammalian neurogenesis. | 1.54e-04 | 69 | 52 | 3 | 18725516 | |
| Pubmed | Angiogenic factors stimulate tubular branching morphogenesis of sonic hedgehog-deficient lungs. | 2.60e-04 | 16 | 52 | 2 | 17187775 | |
| Pubmed | 2.94e-04 | 17 | 52 | 2 | 16778080 | ||
| Pubmed | Fgf21 regulates T-cell development in the neonatal and juvenile thymus. | 3.30e-04 | 18 | 52 | 2 | 28336912 | |
| Pubmed | The sequence and analysis of duplication-rich human chromosome 16. | 3.38e-04 | 90 | 52 | 3 | 15616553 | |
| Pubmed | 3.44e-04 | 222 | 52 | 4 | 35941108 | ||
| Pubmed | Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. | 3.60e-04 | 92 | 52 | 3 | 10493829 | |
| Pubmed | Feto-maternal cholesterol transport regulated by β-Klotho-FGF15 axis is essential for fetal growth. | 3.69e-04 | 19 | 52 | 2 | 37541847 | |
| Pubmed | 4.52e-04 | 21 | 52 | 2 | 21943158 | ||
| Pubmed | DNA Methyltransferase 1 Controls Nephron Progenitor Cell Renewal and Differentiation. | 4.97e-04 | 22 | 52 | 2 | 30518531 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 5.22e-04 | 248 | 52 | 4 | 24006456 | |
| Pubmed | 6.08e-04 | 110 | 52 | 3 | 27889896 | ||
| Pubmed | Specification of CNS macrophage subsets occurs postnatally in defined niches. | 7.51e-04 | 27 | 52 | 2 | 35444273 | |
| Pubmed | 8.08e-04 | 28 | 52 | 2 | 18593464 | ||
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 1.15e-03 | 307 | 52 | 4 | 37499664 | |
| Pubmed | 1.41e-03 | 37 | 52 | 2 | 8076819 | ||
| Pubmed | The transcription factor XBP1 is selectively required for eosinophil differentiation. | 1.41e-03 | 37 | 52 | 2 | 26147683 | |
| Pubmed | 1.46e-03 | 149 | 52 | 3 | 25184681 | ||
| Pubmed | Mutation of ARHGAP9 in patients with coronary spastic angina. | 1.49e-03 | 38 | 52 | 2 | 19911011 | |
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 1.49e-03 | 38 | 52 | 2 | 11756498 | |
| Cytoband | 19q13.1 | 3.45e-05 | 55 | 52 | 3 | 19q13.1 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 5.47e-06 | 355 | 51 | 7 | M45758 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.99e-06 | 177 | 52 | 5 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | droplet-Fat-Scat-21m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-06 | 186 | 52 | 5 | 59710cff3f6f7c318ee2524b44c1a909f312c25e | |
| ToppCell | droplet-Fat-Scat-21m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-06 | 186 | 52 | 5 | de88fafac51049ec1920695844d8ce8057940272 | |
| ToppCell | droplet-Fat-Scat-21m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-06 | 186 | 52 | 5 | 7ff73ab8fed5da779ee9c7bd2e14a8363edb7509 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.97e-06 | 192 | 52 | 5 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.97e-06 | 192 | 52 | 5 | 5f4f44f15d3a2846981e68296643a4634930a211 | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 3.20e-06 | 195 | 52 | 5 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | Epithelial-B_(AT1-AT2-progenitors)|World / shred on cell class and cell subclass (v4) | 2.55e-05 | 146 | 52 | 4 | 4511916904c1fac252cb68e871b782207f8137b3 | |
| ToppCell | lung-Type_II_Pneumocytes|lung / shred on tissue and cell subclass | 2.62e-05 | 147 | 52 | 4 | 8a3039de45b8087f8319e2e37329acf7278219b7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-05 | 158 | 52 | 4 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 159 | 52 | 4 | bea6e96ba40ebfc1e38687bfa1c61fe227c5a84d | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.31e-05 | 167 | 52 | 4 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 4.62e-05 | 170 | 52 | 4 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.62e-05 | 170 | 52 | 4 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.62e-05 | 170 | 52 | 4 | c5b87974dfddf9780051f7f5693eeeb0c606a3fe | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.41e-05 | 177 | 52 | 4 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.41e-05 | 177 | 52 | 4 | 945b2d0723a0a35c767604ae607d2c2d53bf0c82 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.53e-05 | 178 | 52 | 4 | e44b0aa82890ae84fc4d1343f1c65ae2fda69a11 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.65e-05 | 179 | 52 | 4 | 06d412fc096d88de168969466ce422f0ab5553b2 | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 5.65e-05 | 179 | 52 | 4 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-monocytoid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.77e-05 | 180 | 52 | 4 | ba4c1fb55e8f1095bea6968417fefcf5f700926b | |
| ToppCell | droplet-Lung-nan-21m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-05 | 182 | 52 | 4 | 40539ade8c3cd12b61f1cd0d493828e58282796b | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.29e-05 | 184 | 52 | 4 | 49705c8fec565b16216bdf48e83e27521f52d99a | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-05 | 184 | 52 | 4 | 04bd8ab5808fcfa923aa4d0edf6a7f88b7980122 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-05 | 184 | 52 | 4 | e727bf110cb6a91a655c1865b0e93e51e2f9dda3 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.42e-05 | 185 | 52 | 4 | 2adb32096aa3473f8d417e5ce9e65264beca9b52 | |
| ToppCell | PND01-03-samps-Epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.42e-05 | 185 | 52 | 4 | 2b854df79cfe2cb4d2f9c2938a066e0aa3649325 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.56e-05 | 186 | 52 | 4 | 9673367cb53bafb873a01ef6bda11d9f392ce648 | |
| ToppCell | Epithelial-C_(AT2)|World / shred on cell class and cell subclass (v4) | 6.56e-05 | 186 | 52 | 4 | b7b1763fc52b4485d843a4a6727055e6c95ebad3 | |
| ToppCell | facs-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.56e-05 | 186 | 52 | 4 | c7214e762b3b48197fdd0b36a50a4de2550a888f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.56e-05 | 186 | 52 | 4 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.69e-05 | 187 | 52 | 4 | 6ab51e17a7782c2ae6394cad813dc3a2cde70c89 | |
| ToppCell | facs-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.69e-05 | 187 | 52 | 4 | a5318c888b334e8695f38971a7d100b93cdaf04b | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.69e-05 | 187 | 52 | 4 | 23fe3cdd6cc9b067086a8392d104186d300298ea | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.69e-05 | 187 | 52 | 4 | e176b5b051690f840f3b12c8f7c4cc10cbe2bbae | |
| ToppCell | facs-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.69e-05 | 187 | 52 | 4 | 64ba0df991eab8b2632751805d758c5f2711f4d7 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-05 | 188 | 52 | 4 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.83e-05 | 188 | 52 | 4 | 7499e353ea5853d06558b20cedee3c7910425d7d | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.83e-05 | 188 | 52 | 4 | 562f5984efdbbcb8f53ddcee033ccbf9eb678425 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | b81540e097e95158851e07bfd78640ed6e64c2cf | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | 0fda1a3f1e87fadf5309c8267beaa4501983b1dd | |
| ToppCell | PND10-Epithelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-05 | 189 | 52 | 4 | 89349e226a5512833a94b1bf68056a6985fe4afd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 190 | 52 | 4 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.12e-05 | 190 | 52 | 4 | 8ff8c586237cf15f930416710bcff45205fe6f70 | |
| ToppCell | PND14-Epithelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.12e-05 | 190 | 52 | 4 | f1eeef8f201bf7b96c020c8ab53dd7e05b3060ea | |
| ToppCell | droplet-Lung-21m-Epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.12e-05 | 190 | 52 | 4 | 50a8ba20f8153279387c335538bc52bf18ac1fc2 | |
| ToppCell | PND28-Epithelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.12e-05 | 190 | 52 | 4 | 89e5ddd830f70429d5b2fbaf8d0790b033450aa7 | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.12e-05 | 190 | 52 | 4 | d541e076137cf7334bdb0ed69db2f9a27c668c65 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 190 | 52 | 4 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 190 | 52 | 4 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.12e-05 | 190 | 52 | 4 | dc20d323cee2741e39fba597263d6418ae0eadaf | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.12e-05 | 190 | 52 | 4 | ec1bd4929dc82bec2c983a31ece4e3aa82f3a2ab | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.27e-05 | 191 | 52 | 4 | 5f8b3b2d38b37027901db9a1cccdbd1ff70f29de | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.27e-05 | 191 | 52 | 4 | f00d6824bd138b192a996e9f7de57b235bb24c18 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.27e-05 | 191 | 52 | 4 | 2f71f1fb6b5872d84860840b22e789a87ab14eec | |
| ToppCell | droplet-Lung-18m-Epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.27e-05 | 191 | 52 | 4 | 1b59f1cad6c1a6a5938afa9195164918e3ff4e86 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.27e-05 | 191 | 52 | 4 | 4ab3056f9af2a6caed39f32288562f480811cd7b | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.41e-05 | 192 | 52 | 4 | 7ccdb977320d09f21e70e7718ead73eeb56d0c48 | |
| ToppCell | droplet-Fat-Scat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 192 | 52 | 4 | 4098b5170c9995718758a082d1b8bcb86d5a289e | |
| ToppCell | droplet-Fat-Scat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 192 | 52 | 4 | 936028fe851e8dd2b906df0210acc574c017b499 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.41e-05 | 192 | 52 | 4 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| ToppCell | droplet-Fat-Scat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 192 | 52 | 4 | 62e55ed0d46b2e7b07dc42399972a099576cbc5f | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.41e-05 | 192 | 52 | 4 | ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.41e-05 | 192 | 52 | 4 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.41e-05 | 192 | 52 | 4 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.41e-05 | 192 | 52 | 4 | f206c015f091234e2c86dfa66926e97b2ea99690 | |
| ToppCell | PND03-Epithelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.41e-05 | 192 | 52 | 4 | d8c23693f690d4d568585537bbfedda05d505b3d | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.41e-05 | 192 | 52 | 4 | 69963e8dc6d6368243e61da133484eb23225625a | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.41e-05 | 192 | 52 | 4 | bfc68af68fdb99ddfe4add49671e4b4c26e6f962 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.41e-05 | 192 | 52 | 4 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | Epithelial|World / shred on cell class and cell subclass (v4) | 7.41e-05 | 192 | 52 | 4 | 13a3553d9a7c78535679d23d454c63fd08f7d218 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.56e-05 | 193 | 52 | 4 | 5dfa69a680a0859900141c40a446d217aaa747d3 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.56e-05 | 193 | 52 | 4 | ebea35704ac5d21e947ae094313cf2a5205e7014 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.56e-05 | 193 | 52 | 4 | 48ce11778252ae2ef902b30816061b59a3c81695 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.72e-05 | 194 | 52 | 4 | 48c37251518f96524807b5bd1bbc2820637666ad | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.72e-05 | 194 | 52 | 4 | 7b6a34d1f8922b71dcc931421666c1822cec8345 | |
| ToppCell | distal-1-Hematologic-IGSF21+_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.72e-05 | 194 | 52 | 4 | f30c866e5f41ee79bdc6b6e08af962d62b199835 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-F_(Lymphatics)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.72e-05 | 194 | 52 | 4 | 9441202d6fa2ffbef9277d48ae9bc98876c26ec5 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.72e-05 | 194 | 52 | 4 | 435406ebe626c702f7d5a99a3d68ee85aa09be95 | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 7.72e-05 | 194 | 52 | 4 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 7.87e-05 | 195 | 52 | 4 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.87e-05 | 195 | 52 | 4 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.03e-05 | 196 | 52 | 4 | e0447ad2efb021b63c7fef000d39b6b21fbe6113 | |
| ToppCell | Endothelial_cells-Endothelial-B|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 8.03e-05 | 196 | 52 | 4 | 36f95f9ef74eb951e41ef46fd136ceaef45208fc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 8.03e-05 | 196 | 52 | 4 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 8.03e-05 | 196 | 52 | 4 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.03e-05 | 196 | 52 | 4 | bd2c2de103e28b65ea537c22f71225cb0deef1e0 | |
| ToppCell | Control-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 8.03e-05 | 196 | 52 | 4 | e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.03e-05 | 196 | 52 | 4 | 3bca88eede3dd7368715ced02e3bacd1e3e82cab | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.03e-05 | 196 | 52 | 4 | 072a4150ae521c6589b0f7cd60e975fb33715bf4 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-05 | 196 | 52 | 4 | 9554ac6eb5f381bcde3ba40c32aa3fc340974540 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.03e-05 | 196 | 52 | 4 | 006d783a530aa6e1e6545dcc2e6b00bb300fe070 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.03e-05 | 196 | 52 | 4 | e54c08f88779f9fd453a4f5b85aed1f460d8a1e1 | |
| ToppCell | (3)_Macrophage_MARCOneg|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.19e-05 | 197 | 52 | 4 | b0ee2ce1179b60b4542559acb300a34295277dbc | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 8.19e-05 | 197 | 52 | 4 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | tumor_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 8.19e-05 | 197 | 52 | 4 | a05237ee6d31d9eab491dd7007859d6285cf1424 | |
| ToppCell | distal-3-Hematologic-B_cell|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.19e-05 | 197 | 52 | 4 | d426ce59ff3c50051119a2e6b9f9e57c649ad1a9 | |
| ToppCell | normal_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 8.19e-05 | 197 | 52 | 4 | c838d0f64e3b43a616a9e381b8139bfe9aa32da7 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 8.19e-05 | 197 | 52 | 4 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | Tracheal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.35e-05 | 198 | 52 | 4 | 77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d | |
| Drug | dihydrocapsaicin | 1.62e-06 | 11 | 50 | 3 | CID000107982 | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 6.46e-05 | 193 | 50 | 5 | 1464_DN | |
| Drug | Trioxsalen [3902-71-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | 6.78e-05 | 195 | 50 | 5 | 5736_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 6.95e-05 | 196 | 50 | 5 | 4100_DN | |
| Drug | Doxepin hydrochloride [1229-29-4]; Up 200; 12.6uM; HL60; HT_HG-U133A | 7.12e-05 | 197 | 50 | 5 | 2384_UP | |
| Drug | Oxyphenbutazone [129-20-4]; Down 200; 12.4uM; PC3; HT_HG-U133A | 7.12e-05 | 197 | 50 | 5 | 4506_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 7.29e-05 | 198 | 50 | 5 | 3603_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | 7.29e-05 | 198 | 50 | 5 | 6287_DN | |
| Drug | Sulfasalazine [599-79-1]; Down 200; 10uM; PC3; HT_HG-U133A | 7.29e-05 | 198 | 50 | 5 | 6346_DN | |
| Drug | Lysergol [602-85-7]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 7.29e-05 | 198 | 50 | 5 | 3261_DN | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A | 7.29e-05 | 198 | 50 | 5 | 5611_DN | |
| Drug | Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 7.29e-05 | 198 | 50 | 5 | 5645_UP | |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 7.29e-05 | 198 | 50 | 5 | 7325_DN | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 7.29e-05 | 198 | 50 | 5 | 6226_UP | |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 7.29e-05 | 198 | 50 | 5 | 4397_DN | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 7.47e-05 | 199 | 50 | 5 | 7331_DN | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; PC3; HT_HG-U133A | 7.47e-05 | 199 | 50 | 5 | 4071_DN | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A | 7.47e-05 | 199 | 50 | 5 | 4775_UP | |
| Drug | AC1L4187 | 9.86e-05 | 7 | 50 | 2 | CID000099904 | |
| Disease | asialoglycoprotein receptor 1 measurement | 1.75e-05 | 4 | 51 | 2 | EFO_0020164 | |
| Disease | glutathione peroxidase 7 measurement | 4.37e-05 | 6 | 51 | 2 | EFO_0801635 | |
| Disease | atopic eczema | 7.44e-05 | 252 | 51 | 5 | EFO_0000274 | |
| Disease | liver fibrosis measurement | 4.50e-04 | 86 | 51 | 3 | EFO_0010576 | |
| Disease | blood metabolite measurement | 4.92e-04 | 19 | 51 | 2 | EFO_0005664 | |
| Disease | hydrocephalus (implicated_via_orthology) | 4.92e-04 | 19 | 51 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | Ovarian Serous Adenocarcinoma | 7.24e-04 | 23 | 51 | 2 | C1335177 | |
| Disease | endometriosis (is_marker_for) | 8.57e-04 | 25 | 51 | 2 | DOID:289 (is_marker_for) | |
| Disease | lymphocyte percentage of leukocytes | 9.75e-04 | 665 | 51 | 6 | EFO_0007993 | |
| Disease | Hodgkins lymphoma, multiple myeloma, non-Hodgkins lymphoma | 1.08e-03 | 28 | 51 | 2 | EFO_0000183, EFO_0001378, EFO_0005952 | |
| Disease | response to angiotensin receptor blocker | 1.24e-03 | 30 | 51 | 2 | EFO_0010735 | |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 1.68e-03 | 35 | 51 | 2 | DOID:0050861 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ENHAVVCEVEGTAVG | 226 | Q8NHU2 | |
| GIVAEINTKTGESEC | 296 | Q9NR81 | |
| VCEESIAVGTVKHEG | 606 | Q9UBC3 | |
| EGVVENGITTCNGKE | 286 | Q8N556 | |
| CEVSGDVTVDVTGVN | 1081 | Q12802 | |
| VVKVGVTEGSQCTGA | 2731 | Q8TCU4 | |
| DGGVIDSVKTICVGD | 146 | Q8TF65 | |
| EQKVAVVTVDGCDTG | 1476 | Q9HCU4 | |
| CKASGVEGQVVAEGN | 281 | Q76M96 | |
| VAGETAEEVKGCVQQ | 161 | Q9UF12 | |
| VVGCGGFVKSDVEIN | 36 | P69849 | |
| VSAEQEVTCIDGGKT | 246 | Q6PCD5 | |
| QKEGCAGEVVVQLSE | 231 | Q68EN5 | |
| DCGSVDGVIKEVNVS | 26 | P61916 | |
| ASTVVGGDVEFVCKV | 266 | P21802 | |
| VNVGGSVDIVCTVDA | 751 | O60500 | |
| VVGCGGFVKSDVEIN | 36 | Q5JPE7 | |
| KGVQCEVQLVESGEG | 16 | A0A075B6Q5 | |
| DEDGVGSKPQEVHCV | 51 | Q4VC44 | |
| GEKVTITCQASEGIG | 36 | A0A0C4DH26 | |
| TVIVGAKECHVESAG | 166 | Q86VH2 | |
| KLGVATAGCVNEVTE | 121 | Q02556 | |
| QVTGVETDKGQIECQ | 221 | Q8NCN5 | |
| AHCVETGVKITVVAG | 266 | P00740 | |
| VVGCGGFVKSDVEIN | 36 | Q15155 | |
| VVEEECGISIEGVNT | 161 | Q9H3R0 | |
| GNTAEGCVHETQEKQ | 936 | Q9BQG0 | |
| GCVHETQEKQKAGTD | 941 | Q9BQG0 | |
| VATKVCHLGDQLEGV | 106 | O00471 | |
| QGGETIVDVCVNVKD | 786 | Q9BYE9 | |
| TDGVTIGDKGECVIT | 321 | O75460 | |
| QVVGGKAGCVAESTA | 456 | Q9Y6R7 | |
| GQHLEVKCDVESTVG | 351 | Q68DX3 | |
| VEEECDSVGSGVQVV | 141 | Q9H972 | |
| EVTIACKVNHQGGSV | 211 | Q6ZN28 | |
| KVADCVVGKGSSDAV | 276 | Q69YH5 | |
| QVCDGKVSVHVIEGD | 2466 | P49327 | |
| VVVAGDTGCGKSTQV | 181 | Q14147 | |
| DGCVFEKAGVSISVV | 196 | P36551 | |
| EGCVVLEIVGQAATA | 341 | Q5VV67 | |
| DCVVIIGGASNEAGK | 1051 | P22897 | |
| IQVACGGEHTVVLTE | 246 | Q92834 | |
| KLGAEVEVCHVVAVG | 996 | Q9Y2M0 | |
| VVVVKTEDQACGGSL | 246 | Q8NBJ9 | |
| VKGFVGLHCETEVNE | 1296 | Q4LDE5 | |
| EVGVVTFSCKEGHVL | 2341 | Q4LDE5 | |
| EGDECVKTVTDIQGG | 1081 | A4UGR9 | |
| VCIDVGKEFGVATNT | 136 | P49767 | |
| TGEAGKEIVNSEECI | 456 | O95391 | |
| GAEQACEVSVVNGKD | 2061 | Q86WI1 | |
| KVAICQEVKESGQEG | 306 | O75362 | |
| CVVVEGSGQIADVIA | 326 | Q7Z2W7 | |
| VDKVNIEAVGGEKCA | 191 | Q5TAX3 | |
| VCDTGKALVAVVAGN | 91 | Q9Y6Q6 | |
| VESCGVTVCDGKVHI | 521 | Q6PF15 |